Related Experiment Video

Updated: May 19, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

[Deficits in lipid lowering therapy and achieving target lipid concentrations in patients with high risk of a

J Petrus1, F Málek, J Dvořák

  • 1Kardiovaskulární centrum Nemocnice Na Homolce Praha. Filip.Malek@homolka.cz

Vnitrni Lekarstvi
|August 24, 2012
PubMed

Insights

Most high-risk cardiovascular patients have uncontrolled dyslipidemia, with low rates of achieving target LDL-cholesterol levels. This indicates a significant gap in managing lipid disorders for preventing heart events.

Area of Science:

  • Cardiology
  • Clinical Lipidology
  • Preventive Medicine

Context:

  • Analysis of lipid concentrations in 529 high-cardiovascular-risk patients undergoing elective coronary angiography.
  • Study period: January 1st to May 31st, 2010.
  • Patient demographics: 190 females (34%) and 339 males (66%), mean age 66 years.

Purpose:

  • To evaluate the control of dyslipidemia in patients at high cardiovascular risk.
  • To assess achievement of target low-density lipoprotein cholesterol (LDL-C) levels in primary and secondary prevention cohorts.

Summary:

  • Only 36% of primary prevention patients achieved LDL-C < 2.5 mmol/l.
  • Only 28% of secondary prevention patients achieved LDL-C < 2.0 mmol/l.
  • The findings demonstrate inadequate dyslipidemia management in this high-risk population.

Impact:

  • Highlights the need for improved strategies in managing dyslipidemia for cardiovascular event prevention.
  • Underscores the gap between current clinical practice and lipid management guidelines.
  • Emphasizes the importance of optimizing lipid-lowering therapies in high-risk individuals.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...